Financhill
Back

Biogen Vs. Ionis Pharmaceuticals Industry Stock Comparison

Sell
26

BIIB
Biogen

Last Price:
156.02
Seasonality Move:
12.81%
Sell
34

IONS
Ionis Pharmaceuticals

Last Price:
35.43
Seasonality Move:
4.86%
Sell
26
Biogen (BIIB) is a Sell

Is Biogen a Buy, Sell or Hold?

  • The current Biogen [BIIB] share price is $156.00. The Score for BIIB is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
  • BIIB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
34
Ionis Pharmaceuticals (IONS) is a Sell

Is Ionis Pharmaceuticals a Buy, Sell or Hold?

  • The current Ionis Pharmaceuticals [IONS] share price is $35.40. The Score for IONS is 34, which is 32% below its historic median score of 50, and infers higher risk than normal.
  • IONS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

BIIB Stock Price Chart

What is Biogen's stock price today?

  • The Biogen share price today is $156.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIIB is experiencing buying pressure, which is a positive indicator for future bullish movement.

IONS Stock Price Chart

What is Ionis Pharmaceuticals's stock price today?

  • The Ionis Pharmaceuticals share price today is $35.40
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IONS is experiencing buying pressure, which is a positive indicator for future bullish movement.

BIIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -7.82 Sell
Relative Strength Index (14 RSI): 19.08 Sell
Chaikin Money Flow: 1376294 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (164.6 - 184.8) Sell
Bollinger Bands (100): (179.33 - 217.01) Sell

IONS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.31 Sell
Relative Strength Index (14 RSI): 37.41 Sell
Chaikin Money Flow: 1790884 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (36.3 - 39.88) Sell
Bollinger Bands (100): (38.71 - 48.31) Sell

BIIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 162.54 Sell
20-day SMA: 171.75 Sell
50-day SMA: 183.57 Sell
200-day SMA: 208.91 Sell
8-day EMA: 161.79 Sell
20-day EMA: 169.87 Sell
50-day EMA: 181.53 Sell
200-day EMA: 208.1 Sell

IONS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 36.11 Sell
20-day SMA: 37.86 Sell
50-day SMA: 39.09 Sell
200-day SMA: 43.03 Sell
8-day EMA: 35.8 Sell
20-day EMA: 37.26 Sell
50-day EMA: 39.39 Sell
200-day EMA: 42.65 Sell

Biogen Earnings Growth & BIIB Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.32 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.43 per share, and an increase next year of $0.26 per share.

Ionis Pharmaceuticals Earnings Growth & IONS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and an increase next year of $0.03 per share.

Biogen Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ionis Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):